1. 1. Eskander HG, Morsy WY, Elfeky HA, Ali AM. Impact of pharmacovigilance educational intervention on critical care nurses' performance at cancer hospital, Egypt. J Adv Pharm Educ. 2021;11(4):15-23.
2. 2. Almehmadi M, Alzahrani K, Salih MM, Alsharif A, Alsiwiehri N, Shafie A, et al. Assessment of thyroid gland function by evaluating of TSH, FT3 and FT4 hormones in untreated cancer patients. J Adv Pharm Educ. 2020;10(4):37-42.
3. 3. Alhomayani FK, Althumali AM, Alhamyani A, Alsufyani AA, Alharthi NA, Almalki MS. Awareness of hemodialysis patients regarding symptoms of cancer at king Abdul-Aziz specialized hospital, Taif city. Arch Pharm Pract. 2020;11(2):69-80.
4. 4. Stein H, Swerdlow SH, Gascoyne RD, Poppema S, Jaffe ES, Pileri SA. Nodular lymphocyte predominant Hodgkin lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, editors.WHO classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2017:431-4.
5. 5. Meignin V, Briere J, Brice P, Gisselbrecht C, Gaulard P, Janin A. Hodgkin disease with nodular lymphocytic predominance or type I (paragranuloma of Poppema-Lennert): a clinico-pathological entity. Study of 21 cases and review of the literature. Ann Pathol. 2000;20(1):19-24.